Complete Genomics Cuts Wages, Other Costs as it Seeks to Close Series D Financing Round
April 14, 2009
Complete Genomics Cuts Wages, Other Costs as it Seeks to Close Series D Financing Round
The company is in the late stages of closing a Series D investment, but due to the slowdown of the capital markets in recent months, "it has taken us longer than anticipated to close," a company official said.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Complete Genomics Cuts Wages, Other Costs as Financing Round is Delayed
April 10, 2009 / GenomeWeb Daily News - Complete Genomics Starts Integrating Tech Development, Sales with BGI; Focus on Clinical Sequencing
May 7, 2013 / In Sequence - With IBM Help, Coriell Spins off For-Profit Entity to Store Whole-Genome Sequencing Data
January 30, 2013 / Pharmacogenomics Reporter - Customers See BGI's Proposed $117.6M Takeover of Complete Genomics as Positive for Services Market
September 18, 2012 / In Sequence - Complete Aims for Clinical Market as it Readies its WG Haplotyping Tech for Launch
July 18, 2012 / Clinical Sequencing News